Trial intelligence / Profile preview

Mannitol and Voluven for ICG Imaging in Breast Cancer

NCT06768268Phase 2Enrolling by invitation

Sponsor
National Taiwan University Hospital
Start
Jan 2025
Primary completion
Dec 2025
Modality
Inhalation Devices, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Bronchitol in breast cancer, sponsored by National Taiwan University Hospital. Started Jan 2025; status: enrolling by invitation.

02

Drugs

Bronchitol
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT06768268.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06768268.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call